088264552	088264552	CD	B-NP	O
|	|	NN	I-NP	O
ARCCH	ARCCH	NN	I-NP	O
|	|	NN	I-NP	O
39713635	39713635	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4945880	4945880	CD	B-NP	O
|	|	CC	I-NP	O
6/26/2007	6/26/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/4/2007	7/4/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/21/2007	4/21/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
COOLBAUGH	COOLBAUGH	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
J.	J.	NNP	I-NP	O
031-08-99-2	031-08-99-2	CD	I-NP	O
South	South	NNP	I-NP	O
Dakota	Dakota	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/16/07	1/16/07	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
labs/ekg	labs/ekg	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KEASER	KEASER	NNP	B-NP	O
,	,	,	O	O
JR	JR	NNP	B-NP	O
,	,	,	O	O
OMER	OMER	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

MYCOPHENOLATE	MYCOPHENOLATE	JJ	B-NP	B-protein
MOFETIL	MOFETIL	NN	I-NP	I-protein
1000	1000	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

OXYBUTYNIN	OXYBUTYNIN	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
XL	XL	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
GLARGINE	GLARGINE	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NNP	B-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

PRAVASTATIN	PRAVASTATIN	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

PREDNISONE	PREDNISONE	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
SANDIMMUNE	SANDIMMUNE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

FENOFIBRATE	FENOFIBRATE	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
48	48	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/8	10/8	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SANDIMMUNE	SANDIMMUNE	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
REGES	REGES	NNP	B-NP	O
,	,	,	O	O
FAUSTO	FAUSTO	NNP	B-NP	O
T	T	NNP	I-NP	O
BUCK	BUCK	NNP	I-NP	O
JERRY	JERRY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRICOR	TRICOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
155808260	155808260	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
KELLETT	KELLETT	NNP	B-NP	O
,	,	,	O	O
WILTON	WILTON	NNP	B-NP	O
GAYLORD	GAYLORD	NNP	I-NP	O
MILO	MILO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
TRICOR	TRICOR	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
48	48	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
RAGONE	RAGONE	NN	B-NP	O
,	,	,	O	O
JAMAL	JAMAL	NNP	B-NP	O
F	F	NNP	I-NP	O
BERNARD	BERNARD	NNP	I-NP	O
HOUSTON	HOUSTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
20	20	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
CELLCEPT	CELLCEPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NN	I-NP	O
MOFETIL	MOFETIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
TNG	TNG	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
DITROPAN	DITROPAN	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYBUTYNIN	OXYBUTYNIN	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
PRAVACHOL	PRAVACHOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
KWAN	KWAN	NNP	B-NP	O
,	,	,	O	O
JOHNSON	JOHNSON	NNP	B-NP	O
A	A	NNP	I-NP	O
EDMUNDO	EDMUNDO	NNP	I-NP	O
TAD	TAD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TRICOR	TRICOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
155808260	155808260	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
LAMOREE	LAMOREE	NN	B-NP	O
,	,	,	O	O
MARCELLUS	MARCELLUS	NNP	B-NP	O
VICENTE	VICENTE	NNP	I-NP	O
RONALD	RONALD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CYCLOSPORINE	CYCLOSPORINE	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SANDIMMUNE	SANDIMMUNE	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
338863507	338863507	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
by	by	IN	B-PP	O
SLEIMAN	SLEIMAN	NN	B-NP	O
,	,	,	O	O
CARTER	CARTER	NN	B-NP	B-protein
ERNESTO	ERNESTO	NN	I-NP	I-protein
BRUNO	BRUNO	NN	I-NP	I-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVACHOL	PRAVACHOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
580110262	580110262	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
muscle	muscle	NN	B-NP	O
aches	ache	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
PREDNISOLONE	PREDNISOLONE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
PHOSPHATE	PHOSPHATE	NN	I-NP	O
5MG/5ML	5MG/5ML	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
light	light	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
heavy	heavy	JJ	I-NP	O
lifting	lift	VBG	I-NP	O
or	or	CC	I-VP	O
driving	drive	VBG	I-VP	O
x	x	NN	B-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

ok	ok	NN	B-NP	O
to	to	TO	B-VP	O
shower	shower	VB	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
swimming	swimming	NN	I-NP	O
or	or	CC	I-NP	O
bathing	bathing	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
Lift	Lift	NN	B-NP	O
restrictions	restriction	NNS	I-NP	O
:	:	:	O	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
lift	lift	VB	I-VP	O
greater	great	JJR	B-NP	O
then	then	RB	B-ADVP	O
10-15	10-15	CD	B-NP	O
pounds	pound	NNS	I-NP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Heart	Heart	NNP	B-NP	O
failure	failure	NN	I-NP	O
Clinic	Clinic	NNP	B-NP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
1992	1992	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Trochanteric	Trochanteric	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
trochanteric	trochanteric	JJ	I-NP	O
bursitis	bursitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Dyslipidemia	Dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DJD	DJD	NN	I-NP	O
spine	spine	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
OA	OA	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
spine	spine	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hx	Hx	NN	I-NP	O
vocal	vocal	JJ	I-NP	O
cord	cord	NN	I-NP	O
injury	injury	NN	I-NP	O
postop	postop	VBP	B-VP	O
Hx	Hx	NN	B-NP	O
gastritis	gastritis	NN	I-NP	O
with	with	IN	B-PP	O
UGIB	UGIB	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
Hx	Hx	NN	I-NP	O
postop	postop	VBP	B-VP	O
seizure	seizure	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
LAD	LAD	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
15	15	CD	B-NP	O
years	year	NNS	I-NP	O
following	follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
multiplicity	multiplicity	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
allograft	allograft	NN	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
carotid	carotid	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
carotid	carotid	NN	B-NP	O
stenting	stente	VBG	B-VP	O
in	in	IN	B-PP	O
January	January	NNP	B-NP	O
2006	2006	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
TIA	TIA	NN	B-NP	B-protein
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
significant	significant	JJ	B-NP	O
obesity.Her	obesity.Her	NN	I-NP	O
baseline	baseline	NN	I-NP	O
renal	renal	JJ	I-NP	O
cr	cr	NN	I-NP	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
LCX	LCX	NN	I-NP	B-protein
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
in	in	IN	B-PP	O
November	November	NNP	B-NP	O
2006	2006	CD	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
meds	med	NNS	I-NP	O
includes	include	VBZ	B-VP	O
CellCept	CellCept	NNP	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
TriCor	TriCor	NN	B-NP	O
,	,	,	O	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Pravachol	Pravachol	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Ditropan	Ditropan	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
vitamins	vitamin	NNS	B-NP	O
.	.	.	O	O

Elective	Elective	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
Was	Be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
today	today	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
annual	annual	JJ	I-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
double	double	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
LeftnCX	LeftnCX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Proximal	Proximal	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
CX	CX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Mid	Mid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
MARG1	MARG1	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
Ostial	Ostial	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Successful	Successful	JJ	B-NP	O
PTCA/Stenting	PTCA/Stenting	NN	I-NP	O
-	-	HYPH	O	O
LAD	LAD	NN	B-NP	B-protein
using	use	VBG	B-VP	O
XB3	XB3	NN	B-NP	O
.5	.5	CD	I-NP	O
guide	guide	NN	I-NP	O
,	,	,	O	O
BMW	BMW	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
predilated	predilate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
2mm	2mm	NN	I-NP	O
balloon	balloon	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
DES	DES	NNP	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
-LRB-	-LRB-	IN	B-PP	O
3	3	CD	B-NP	O
by	by	IN	B-PP	O
18	18	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-ADJP	O
and	and	CC	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
by	by	IN	B-PP	O
18	18	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
cypher	cypher	NN	I-NP	O
stents	stent	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
postdilated	postdilate	VBN	I-VP	O
to	to	TO	B-PP	O
3.2	3.2	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
residual	residual	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
Right	Right	NN	I-NP	O
groin	groin	NN	I-NP	O
access	access	NN	I-NP	O
was	be	VBD	B-VP	O
closed	close	VBN	I-VP	O
with	with	IN	B-PP	O
Starclose	Starclose	NN	B-NP	O
.	.	.	O	O

PCI	PCI	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
today	today	NN	B-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
planned	plan	VBN	I-NP	O
PCI	PCI	NN	I-NP	O
of	of	IN	B-PP	O
LCX	LCX	NN	B-NP	B-protein
in	in	IN	B-PP	O
1-3	1-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Check	Check	VB	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
PCI	PCI	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
today	today	NN	B-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
planned	plan	VBN	I-NP	O
PCI	PCI	NN	I-NP	O
of	of	IN	B-PP	O
LCX	LCX	NN	B-NP	B-protein
in	in	IN	B-PP	O
1-3	1-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Check	Check	VB	B-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
6/9/07	6/9/07	CD	B-NP	O
Up	Up	NN	I-NP	O
,	,	,	O	O
eating	eat	VBG	B-VP	O
and	and	CC	I-VP	O
voiding	void	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Ambulating	Ambulate	VBG	B-VP	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
-	-	HYPH	B-ADVP	O
``	``	``	B-VP	O
tired	tire	VBN	I-VP	O
''	''	''	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Chest	Chest	NNP	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
groin	groin	NN	B-NP	O
or	or	CC	O	O
flank	flank	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
questions	question	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
activity	activity	NN	B-NP	O
,	,	,	O	O
medications	medication	NNS	B-NP	O
reviewed	review	VBN	B-VP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
96.4	96.4	CD	B-NP	O
80-90s	80-90s	CD	I-NP	O
110/60	110/60	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
voiding	void	VBG	B-VP	O
to	to	TO	B-PP	O
BR	BR	NN	B-NP	B-protein
NAD	NAD	NN	I-NP	I-protein
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
not	not	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
.	.	.	O	O

COR	COR	NN	B-NP	O
RRR	RRR	NN	I-NP	O
,	,	,	O	O
S1S2	S1S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmur	murmur	NN	I-NP	O
appreciated	appreciate	VBN	B-NP	O
Lungs	Lung	NNS	I-NP	O
-	-	HYPH	B-NP	O
CTA	CTA	NN	I-NP	B-protein
bilat	bilat	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
RRW	RRW	NN	I-NP	B-protein
EXT	EXT	NN	I-NP	I-protein
-	-	HYPH	O	O
warm	warm	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
Right	Right	NNP	I-NP	O
Groin-soft	Groin-soft	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
or	or	CC	I-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

Palpable	Palpable	JJ	B-NP	O
femoral	femoral	JJ	I-NP	O
pulse	pulse	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
:	:	:	O	I-protein
SR	SR	NN	B-NP	I-protein
at	at	IN	B-PP	O
95	95	CD	B-NP	O
wtih	wtih	NN	I-NP	O
inc	inc	NN	I-NP	O
RBBB	RBBB	NN	I-NP	O
,	,	,	O	O
flat	flat	JJ	B-NP	O
T	T	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

TELE	TELE	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
tele	tele	NN	I-NP	O
events	event	NNS	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
years	year	NNS	I-NP	O
post	post	IN	B-PP	O
transplant	transplant	NN	B-NP	O
,	,	,	O	O
resume	resume	VB	B-VP	O
meds	med	NNS	B-NP	O
per	per	IN	B-PP	O
transplant	transplant	NN	B-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
post	post	IN	B-PP	O
Cypher	Cypher	NNP	B-NP	O
DES	DES	NNP	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
residual	residual	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
see	see	VBP	B-VP	O
cath	cath	NN	B-NP	O
report	report	NN	I-NP	O
for	for	IN	B-PP	O
full	full	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
daily	daily	JJ	I-NP	O
x	x	NN	I-NP	O
life	life	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
minimum	minimum	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
months	month	NNS	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
out	out	RP	B-PRT	O
indef	indef	NN	B-NP	O
.	.	.	O	O

Importance	Importance	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
stressed	stress	VBD	B-VP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
understands	understand	NNS	I-NP	O
!	!	.	O	O

SL	SL	NN	B-NP	O
TNG	TNG	NN	I-NP	O
prn	prn	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

AM	AM	NN	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
pending	pende	VBG	B-VP	O
.	.	.	O	O

*	*	SYM	B-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

*	*	SYM	B-NP	O
RHYTHM	RHYTHM	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
palps	palp	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tachy/brady	tachy/brady	JJ	I-NP	O
tele	tele	NN	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	B-protein
HTN	HTN	NN	I-NP	I-protein
:	:	:	O	O
BP	BP	NN	B-NP	O
well	well	RB	B-ADVP	O
controlled	control	VBD	B-VP	O
HR	HR	NN	B-NP	B-protein
up	up	RP	B-PRT	O
some	some	DT	B-NP	O
on	on	IN	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
LIPIDS	LIPIDS	NN	I-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
cont	cont	VB	I-VP	O
pravachol	pravachol	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
tricor	tricor	NN	B-NP	O
48	48	CD	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
baseline	baseline	NN	B-NP	O
1.5	1.5	CD	I-NP	O
-	-	HYPH	I-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
AM	AM	VBP	B-VP	O
pending	pending	JJ	B-ADJP	O
.	.	.	O	O

encouraged	encourage	VBN	B-VP	O
increased	increase	VBD	B-VP	O
PO	PO	NN	B-NP	O
intake	intake	NN	I-NP	O
over	over	IN	B-PP	O
next	next	JJ	B-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
falls	fall	VBZ	B-VP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
renal	renal	JJ	B-NP	O
fx	fx	NN	I-NP	O
rechecked	rechecke	VBD	B-VP	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
with	with	IN	B-PP	O
local	local	JJ	B-NP	O
MD.	MD.	NNP	I-NP	O
**	**	NNP	I-NP	O
ENDO	ENDO	NNP	I-NP	O
:	:	:	O	O
check	check	VB	B-VP	O
hgb	hgb	NN	B-NP	B-protein
a1c	a1c	NN	I-NP	I-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

cont	cont	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
**	**	SYM	B-NP	O
DISPO	DISPO	NN	I-NP	B-protein
:	:	:	O	O
stable	stable	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
ready	ready	JJ	I-ADJP	O
for	for	IN	B-PP	O
DC	DC	NN	B-NP	B-cell_type
this	this	DT	B-NP	O
am	am	NN	I-NP	O
pending	pende	VBG	B-PP	O
labs	lab	NNS	B-NP	O
,	,	,	O	O
attending	attend	VBG	B-VP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

FU	FU	NN	B-NP	O
with	with	IN	B-PP	O
Transplant	Transplant	NN	B-NP	B-protein
team	team	NN	I-NP	I-protein
,	,	,	O	O
they	they	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
contact	contact	NN	B-NP	O
regarding	regard	VBG	B-VP	O
date	date	NN	B-NP	O
of	of	IN	B-PP	O
staged	staged	JJ	B-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
LCx	LCx	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
call	call	VB	I-VP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
Questions	Question	NNS	I-NP	O
answered	answer	VBD	B-VP	O
.	.	.	O	O

Addendum	Addendum	NN	B-NP	O
:	:	:	O	O
renal	renal	JJ	B-NP	O
fx	fx	NN	I-NP	O
fine	fine	NN	I-NP	O
but	but	CC	O	O
asxatic	asxatic	JJ	B-NP	O
MB	MB	NN	I-NP	O
bump	bump	NN	I-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
,	,	,	O	O
rechecking	rechecking	NN	B-NP	O
and	and	CC	I-NP	O
dc	dc	NN	I-NP	B-cell_type
if	if	IN	B-SBAR	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
keep	keep	VB	B-VP	O
until	until	IN	B-PP	O
tomorrow	tomorrow	NN	B-NP	O
if	if	IN	B-SBAR	O
up	up	IN	B-PRT	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
you	you	PRP	B-NP	O
must	must	MD	B-VP	O
take	take	VB	I-VP	O
aspirin	aspirin	NN	B-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
-	-	HYPH	O	O
you	you	PRP	B-NP	O
must	must	MD	B-VP	O
take	take	VB	I-VP	O
plavix	plavix	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
-	-	HYPH	B-NP	O
DO	DO	NN	I-NP	O
NOT	NOT	NN	I-NP	O
STOP	STOP	NN	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
OR	OR	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
ANY	ANY	NNP	I-NP	O
REASON	REASON	NNP	I-NP	O
UNLESS	UNLESS	NNP	I-NP	O
SPEAK	SPEAK	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
CARDIOLOGIST	CARDIOLOGIST	NNP	I-NP	O
FIRST	FIRST	NNP	I-NP	O
!	!	.	O	O
!	!	.	O	B-cell_line
!	!	.	O	B-protein
-	-	HYPH	O	O
resume	resume	JJ	B-NP	O
other	other	JJ	I-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
usual	usual	JJ	B-NP	O
doses	dose	NNS	I-NP	O
-	-	:	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
3/19	3/19	CD	I-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
contrast	contrast	NN	B-NP	O
-	-	HYPH	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
heart	heart	NN	B-NP	O
transplant	transplant	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-	-	HYPH	B-NP	O
drink	drink	NN	I-NP	O
plenty	plenty	NN	I-NP	O
of	of	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
falls	fall	VBZ	B-VP	O
please	please	NN	B-NP	O
call	call	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	O	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
return	return	VB	I-VP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
intervention	intervention	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
weeks	week	NNS	I-NP	O
-	-	:	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
through	through	IN	B-PP	O
transplant	transplant	NN	B-NP	O
clinic	clinic	NN	I-NP	O
-	-	HYPH	B-NP	O
call	call	NN	I-NP	O
with	with	IN	B-PP	O
questions	question	NNS	B-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DANES	DANES	NNP	B-NP	O
,	,	,	O	O
CRUZ	CRUZ	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FW52	FW52	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/16/07	1/16/07	CD	I-NP	O
@	@	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
39	39	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

